Global Empty Intravenous (IV) Bags Market, By Product (PVC and non-PVC), Type (Single and Multi-chamber) – Industry Trends and Forecast to 2031.
Empty Intravenous (IV) Bags Market Analysis and Size
In veterinary medicine, empty intravenous (IV) bags serve as crucial tools for administering fluids, medications, and other treatments to animals. Veterinarians rely on IV bags to provide hydration, deliver medications, and support critical care interventions during surgeries, emergencies, and medical treatments for animals. These bags are available in various sizes and configurations to accommodate different animal species and treatment requirements. Whether it is for small companion animals such as cats and dogs or large livestock such as horses and cattle, IV bags play a vital role in veterinary healthcare by ensuring accurate dosing and safe delivery of intravenous therapies.
The global empty intravenous (IV) bags market size was valued at USD 3.91 billion in 2023 and is projected to reach USD 5.96 billion by 2031, with a CAGR of 5.40% during the forecast period of 2024 to 2031.
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024-2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (PVC and non-PVC), Type (Single and Multi-chamber)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Brazil, and Argentina
|
|
Market Players Covered
|
Sippex IV Bag (U.S.), Technoflex (Japan), Wipak Group (Germany), Baxter (U.S.), B. Braun (Germany), ICU Medical, Inc. (U.S.), POLYCINE GmbH (Germany), RENOLIT SE (Germany), Pfizer Inc. (U.S.), West Pharmaceutical Services Inc. (U.S.), Jinan Youlyy Industrial Co., Ltd. (China), and Jiangsu Eyoung Medical Devices Co. Ltd. (China)
|
|
Market Opportunities
|
|
Market Definition
Empty intravenous (IV) bags refer to medical containers designed to hold various intravenous fluids, such as saline solution or medications, but are devoid of content. They are typically made of flexible plastic and come in various sizes to accommodate different volumes of fluids. These bags are crucial in healthcare settings for administering treatments directly into the bloodstream. Once filled with the required solution or medication, they are connected to IV lines and used for intravenous therapy, transfusions, or hydration. Empty IV bags are sterile and disposable, ensuring patient safety and hygiene during medical procedures.
Empty Intravenous (IV) Bags Market Dynamics
Drivers
- Rising Prevalence of Chronic Diseases
Chronic diseases such as cancer, diabetes, and cardiovascular disorders often require ongoing intravenous therapies for medication administration, hydration, and nutritional support. As the incidence of chronic diseases continues to increase due to factors such as aging populations, sedentary lifestyles, and unhealthy dietary habits, the need for IV bags for disease management and treatment escalates. Healthcare facilities, including hospitals, clinics, and home healthcare settings, require a consistent supply of IV bags to meet the growing demand for intravenous treatments.
- Increasing Technological Innovations in IV Bags
Advancements such as the development of more durable and flexible materials, improved closure systems to maintain sterility, and enhanced compatibility with various medications contribute to the market growth. Features such as integrated ports for easy access and administration of medications, as well as compatibility with infusion pumps and other medical devices, enhance the usability and efficiency of IV bags, driving their adoption in healthcare settings.
Opportunities
- Expansion of Home Healthcare Services
As healthcare shifts towards decentralized models and patients seek alternatives to traditional hospital stays, there's a rising demand for IV bags to facilitate intravenous therapies in the comfort of patients' homes. Home healthcare services offer convenience and cost-effectiveness for managing chronic conditions, post-operative care, and palliative treatments, driving the need for IV bags for fluid administration, medication delivery, and nutritional support outside clinical settings. This trend empowers patients to take greater control of their healthcare and creates a growing market for IV bags tailored for home use, with features emphasizing ease of use, portability, and safety.
- Rising Government Initiatives
Governments often invest in healthcare infrastructure, including hospitals and clinics, which increases the demand for IV bags for fluid administration during treatments and surgeries. Favorable reimbursement policies for intravenous therapies incentivize healthcare providers to utilize IV bags, boosting market growth. Government initiatives also focus on regulating the quality and safety standards of medical devices, including IV bags, ensuring their compliance with stringent regulations, which further stimulates market demand. Awareness campaigns and educational programs sponsored by governments raise awareness among healthcare professionals and patients about the importance of intravenous therapy, fostering the adoption of IV bags in clinical settings.
Restraints/Challenges
- High Concerns Regarding Plastic Pollution
As the healthcare industry increasingly recognizes the environmental impact of single-use plastics, there is growing pressure to seek alternative, more sustainable packaging solutions. The substantial use of plastic IV bags contributes to plastic waste generation, raising environmental concerns and prompting healthcare facilities to explore eco-friendly alternatives. Moreover, public awareness campaigns and regulatory initiatives aimed at reducing plastic consumption may lead to shifts in consumer preferences towards greener packaging options, potentially impacting the demand for traditional plastic IV bags.
- High Volatility in Raw Material Prices
Fluctuations in the prices of key materials, such as plastic resins, which are integral to IV bag manufacturing, can directly impact production costs. Manufacturers may face challenges in maintaining stable pricing for IV bags, leading to uncertainty for both producers and consumers. Sudden spikes in raw material prices can squeeze profit margins and hinder investment in innovation or expansion initiatives within the industry.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In February 2023, Bowmed Ibisqus Company launched Levofloxacin fluid bags in a ready-to-use format, wrapped with foil to shield the fluid from light. This innovation not only addressed the need for convenient IV solutions but also potentially impacted the demand for empty IV bags in the market as hospitals and healthcare facilities transitioned to this new format
- In January 2022, the U.S. FDA approved B. Braun Medical Inc.'s new pharmaceutical production facility in Daytona Beach, Florida. This facility was designated to manufacture 500 mL and 1,000 mL Excel Plus IV Bags with 0.9% Sodium Chloride for Injection, potentially contributing to the supply of empty IV bags in the market.
- In April 2021, Winpak Ltd. and Wipak Walothen GmbH collaborates to establish Wiicare, a brand focused on delivering healthcare packaging solutions, including medical fluid containers. This collaboration aimed to address the growing demand for innovative packaging solutions in the medical industry, potentially impacting the empty intravenous (IV) bags market
Empty Intravenous (IV) Bags Market Scope
The market is segmented on the basis of type, and product type. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- PVC
- Non-PVC
Product Type
- Single Chamber
- Multi-chamber
Empty Intravenous (IV) Bags Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, type, and product type as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Brazil, and Argentina.
North America dominates the market, primarily driven by the widespread adoption of non-PVC bags in the region. This trend is fueled by the increasing acceptance of innovative healthcare technologies. As a result, the demand for empty IV bags is expected to continue rising in North America throughout the forecast period. The region's proactive embrace of advancements in healthcare, including safer and more eco-friendly packaging solutions, further propels the growth trajectory of the empty IV bags market in this region.
Asia-Pacific is expected to experience substantial growth in the market, driven by several factors. These include high disease prevalence, particularly among the aging population, coupled with better reimbursement policies and escalating investments to enhance healthcare infrastructure. Furthermore, the increasing consumption of unhealthy food habits contributes to the rising demand for medical interventions, including intravenous therapies. However, despite these growth drivers, challenges such as low awareness about healthcare practices persist, influencing the market dynamics in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Empty Intravenous (IV) Bags Market Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the market are:
- Sippex IV Bag (U.S.)
- Technoflex (Japan)
- Wipak Group (Germany)
- Baxter (U.S.)
- B. Braun (Germany)
- ICU Medical, Inc. (U.S.)
- POLYCINE GmbH (Germany)
- RENOLIT SE (Germany)
- Pfizer Inc. (U.S.)
- West Pharmaceutical Services Inc. (U.S.)
- Jinan Youlyy Industrial Co., Ltd. (China)
- Jiangsu Eyoung Medical Devices Co. Ltd. (China)
SKU-